Cargando…

Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study

BACKGROUND AND AIMS: Thrombocytopenia occurs frequently in patients with cirrhosis. The immature platelet fraction (IPF%) is measured to differentiate the causes of thrombocytopenia. To date the relevance of thrombopoietin (TPO) in the context of cirrhosis is unknown. The aim of our study was to inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Rauber, Philip, Lammert, Frank, Grotemeyer, Katharina, Appenrodt, Beate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810997/
https://www.ncbi.nlm.nih.gov/pubmed/29438423
http://dx.doi.org/10.1371/journal.pone.0192271
_version_ 1783299795111116800
author Rauber, Philip
Lammert, Frank
Grotemeyer, Katharina
Appenrodt, Beate
author_facet Rauber, Philip
Lammert, Frank
Grotemeyer, Katharina
Appenrodt, Beate
author_sort Rauber, Philip
collection PubMed
description BACKGROUND AND AIMS: Thrombocytopenia occurs frequently in patients with cirrhosis. The immature platelet fraction (IPF%) is measured to differentiate the causes of thrombocytopenia. To date the relevance of thrombopoietin (TPO) in the context of cirrhosis is unknown. The aim of our study was to investigate the cause of thrombocytopenia in patients with liver cirrhosis by measuring IPF%, TPO and spleen size. In addition we examined the use of IPF% to evaluate the severity of cirrhosis and its complications. METHODS: Overall, we included 88 in-patients with cirrhosis in our study. The collected data comprises current health status, blood parameters, severity of cirrhosis evaluated by Child-Pugh score and MELD score, spleen diameter, ascites and esophageal varices. The IPF% was measured using an automatic hematology analyzer. TPO was measured with ELISA. RESULTS: IPF% (p = 0.003) and spleen diameter (p = 0.001) were significantly higher in patients with thrombocytopenia. There was no significant difference in TPO between patients with and without thrombocytopenia. The mean values of IPF% varied significantly (p = 0.044) in Child-Pugh stages. IPF% was significantly (p = 0.005) elevated in patients with esophageal varices. Moreover, IPF% higher than 3.85% displayed sensitivity of 76.6% and specificity of 52.4% with an area under receiver operating curve characteristics of 0.669 for the presence of esophageal varices. CONCLUSION: On closer examination of the three compartments known to have an influence on platelet count splenomegaly seems to be the major cause of thrombocytopenia in patients with cirrhosis according to current knowledge. Higher IPF% in patients with thrombocytopenia indicates peripheral consumption of platelets. The relation between spleen diameter and platelet count indicates the spleen to be the major place of platelets’ consumption. TPO did not differ between patients with and without thrombocytopenia. Furthermore, we cannot exclude an influence of impaired thrombopoietin synthesis on platelet counts. The association between IPF% and platelet count suggests that there is physiological regulation of platelets in patients with cirrhosis. In our study IPF% is associated with esophageal varices and the stage of cirrhosis. Further studies are needed to confirm these results.
format Online
Article
Text
id pubmed-5810997
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-58109972018-02-28 Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study Rauber, Philip Lammert, Frank Grotemeyer, Katharina Appenrodt, Beate PLoS One Research Article BACKGROUND AND AIMS: Thrombocytopenia occurs frequently in patients with cirrhosis. The immature platelet fraction (IPF%) is measured to differentiate the causes of thrombocytopenia. To date the relevance of thrombopoietin (TPO) in the context of cirrhosis is unknown. The aim of our study was to investigate the cause of thrombocytopenia in patients with liver cirrhosis by measuring IPF%, TPO and spleen size. In addition we examined the use of IPF% to evaluate the severity of cirrhosis and its complications. METHODS: Overall, we included 88 in-patients with cirrhosis in our study. The collected data comprises current health status, blood parameters, severity of cirrhosis evaluated by Child-Pugh score and MELD score, spleen diameter, ascites and esophageal varices. The IPF% was measured using an automatic hematology analyzer. TPO was measured with ELISA. RESULTS: IPF% (p = 0.003) and spleen diameter (p = 0.001) were significantly higher in patients with thrombocytopenia. There was no significant difference in TPO between patients with and without thrombocytopenia. The mean values of IPF% varied significantly (p = 0.044) in Child-Pugh stages. IPF% was significantly (p = 0.005) elevated in patients with esophageal varices. Moreover, IPF% higher than 3.85% displayed sensitivity of 76.6% and specificity of 52.4% with an area under receiver operating curve characteristics of 0.669 for the presence of esophageal varices. CONCLUSION: On closer examination of the three compartments known to have an influence on platelet count splenomegaly seems to be the major cause of thrombocytopenia in patients with cirrhosis according to current knowledge. Higher IPF% in patients with thrombocytopenia indicates peripheral consumption of platelets. The relation between spleen diameter and platelet count indicates the spleen to be the major place of platelets’ consumption. TPO did not differ between patients with and without thrombocytopenia. Furthermore, we cannot exclude an influence of impaired thrombopoietin synthesis on platelet counts. The association between IPF% and platelet count suggests that there is physiological regulation of platelets in patients with cirrhosis. In our study IPF% is associated with esophageal varices and the stage of cirrhosis. Further studies are needed to confirm these results. Public Library of Science 2018-02-13 /pmc/articles/PMC5810997/ /pubmed/29438423 http://dx.doi.org/10.1371/journal.pone.0192271 Text en © 2018 Rauber et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Rauber, Philip
Lammert, Frank
Grotemeyer, Katharina
Appenrodt, Beate
Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study
title Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study
title_full Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study
title_fullStr Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study
title_full_unstemmed Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study
title_short Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study
title_sort immature platelet fraction and thrombopoietin in patients with liver cirrhosis: a cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810997/
https://www.ncbi.nlm.nih.gov/pubmed/29438423
http://dx.doi.org/10.1371/journal.pone.0192271
work_keys_str_mv AT rauberphilip immatureplateletfractionandthrombopoietininpatientswithlivercirrhosisacohortstudy
AT lammertfrank immatureplateletfractionandthrombopoietininpatientswithlivercirrhosisacohortstudy
AT grotemeyerkatharina immatureplateletfractionandthrombopoietininpatientswithlivercirrhosisacohortstudy
AT appenrodtbeate immatureplateletfractionandthrombopoietininpatientswithlivercirrhosisacohortstudy